GLUCOSE

Back

CLINICAL SIGNIFICANCE
Blood sugar levels are regulated by liver, which ensures that levels are maintained within the precise values. A fall in blood glucose to a critical level leads to dysfunction to the central nervous system. This manifests as hypoglycemia and is characterized by muscle weakness, lack of coordination and mental confusion. Further decrease of blood glucose level leads to hypoglycaemic coma.

Hyperglycaemia most commonly occurs at deficiency of insulin a condition known as diabetes mellitus. This disease is characterized by elevation of blood glucose to such extent that the renal threshold is exceeded and sugar appears to the urine. Blood glucose measurement is used as a screening test for diabetes mellitus where there is suspected hyperglycaemia, gestational diabetes, acute hepatitis and pancreatitis. Elevated glucose levels are also seen at endocrine disorders such as pheochromocytoma, thyrotoxitis, Cushing’s syndrome, pancreatitic diseases like acute and chronic pancreatitis, cystic fibrosis, neoplasms of pancreas. Reduced glucose levels are observed at glucagons deficiency, carcinoma of adrenal gland, carcinoma of stomach, fibrosarcoma, hypopituitorism, Addison’s disease, hypothyroidism, automatic nervous system disorder, ketotic hypoglycemis, Ztterson’s syndrome, galactosemia etc.
CHARACTERISTICS

Form: Liquid ready-to-use
Shelf life: 24 months @ 2-8 C
On-Board Stability: 60 days
Sample: Non hemolyzed serum, or fluoride, iodoacetic-plasma
Detection limit: 0.3 mg/dL
Linearity: 1.9–600 mg/dL


Packaging
For Use On
MEDILYZER
EX-OLYMPUS
GENERAL PURPOSE
SIEMENS ADVIA
Packaging
6x200 Tests
4x750 Tests
R1 4x125 mL
Please Request Info